文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

γδ T 细胞受体来源于乳腺癌浸润 T 淋巴细胞,介导抗肿瘤反应。

γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.

机构信息

Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.

出版信息

Cancer Immunol Res. 2020 Apr;8(4):530-543. doi: 10.1158/2326-6066.CIR-19-0513. Epub 2020 Feb 4.


DOI:10.1158/2326-6066.CIR-19-0513
PMID:32019779
Abstract

γδ T cells in human solid tumors remain poorly defined. Here, we describe molecular and functional analyses of T-cell receptors (TCR) from tumor-infiltrating γδ T lymphocytes (γδ TIL) that were in direct contact with tumor cells in breast cancer lesions from archival material. We observed that the majority of γδ TILs harbored a proinflammatory phenotype and only a minority associated with the expression of IL17. We characterized TCRγ or TCRδ chains of γδ TILs and observed a higher proportion of Vδ2 T cells compared with other tumor types. By reconstructing matched Vδ2 TCRγ and TCRδ pairs derived from single-cell sequencing, our data suggest that γδ TILs could be active against breast cancer and other tumor types. The reactivity pattern against tumor cells depended on both the TCRγ and TCRδ chains and was independent of additional costimulation through other innate immune receptors. We conclude that γδ TILs can mediate tumor reactivity through their individual γδ TCR pairs and that engineered T cells expressing TCRγ and δ chains derived from γδ TILs display potent antitumor reactivity against different cancer cell types and, thus, may be a valuable tool for engineering immune cells for adoptive cell therapies.

摘要

γδ T 细胞在人体实体肿瘤中的特征仍不明确。在这里,我们描述了来自乳腺癌病变中与肿瘤细胞直接接触的肿瘤浸润 γδ T 淋巴细胞 (γδ TIL) 的 T 细胞受体 (TCR) 的分子和功能分析。我们观察到,大多数 γδ TIL 具有促炎表型,只有少数与 IL17 的表达相关。我们对 γδ TIL 的 TCRγ 或 TCRδ 链进行了表征,并观察到与其他肿瘤类型相比,Vδ2 T 细胞的比例更高。通过对来自单细胞测序的匹配 Vδ2 TCRγ 和 TCRδ 对进行重建,我们的数据表明 γδ TIL 可能对乳腺癌和其他肿瘤类型具有活性。针对肿瘤细胞的反应模式取决于 TCRγ 和 TCRδ 链,并且独立于通过其他先天免疫受体进行的额外共刺激。我们得出结论,γδ TIL 可以通过其各自的 γδ TCR 对介导肿瘤反应,并且表达源自 γδ TIL 的 TCRγ 和 δ 链的工程化 T 细胞对不同的癌细胞类型具有强大的抗肿瘤反应性,因此可能是用于过继细胞疗法的免疫细胞工程的有价值的工具。

相似文献

[1]
γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.

Cancer Immunol Res. 2020-2-4

[2]
Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors.

J Natl Cancer Inst. 1996-4-3

[3]
Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.

J Immunol. 2013-5-17

[4]
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

J Exp Med. 1996-4-1

[5]
Renal Cell Carcinoma-Infiltrating CD3 Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.

Curr Issues Mol Biol. 2021-5-27

[6]
Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors.

J Leukoc Biol. 2019-12-13

[7]
γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function.

Cancer Immunol Immunother. 2024-7-2

[8]
γδ T cells in cancer immunotherapy.

Oncotarget. 2017-1-31

[9]
Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.

Cancer Biol Ther. 2009-8-8

[10]
The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.

Front Immunol. 2020

引用本文的文献

[1]
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HRHER2 breast cancer via CX3CR1 macrophages.

Nat Cancer. 2025-7-7

[2]
Remodelling hypoxic TNBC microenvironment restores antitumor efficacy of Vγ9Vδ2 T cell therapy.

Br J Cancer. 2025-5-28

[3]
Application of mass cytometry in the immune microenvironment of breast cancer.

Med Oncol. 2025-5-19

[4]
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells.

Curr Oncol. 2025-2-28

[5]
The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.

Front Immunol. 2024-11-15

[6]
The therapeutic role of γδT cells in TNBC.

Front Immunol. 2024

[7]
Update on current and new potential immunotherapies in breast cancer, from bench to bedside.

Front Immunol. 2024-2-15

[8]
Gamma/delta T cells as cellular vehicles for anti-tumor immunity.

Front Immunol. 2024-1-11

[9]
The capability of heterogeneous γδ T cells in cancer treatment.

Front Immunol. 2023

[10]
Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies.

Front Immunol. 2023-6-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索